NeuroVasx out of Maple Grove, Minnesota received European regulatory approval to market the firm’s innovative polymer based intracranial aneurysm ablation system.
cPAX is a polymer strand delivered through a microcatheter using the same delivery technique as the currently used platinum coil technology. cPAX was designed to achieve more complete filling of the aneurysm using fewer devices and provide the physician the ability to detach the device at any point versus a fixed detachment zone common to platinum coils. The polymeric material also allows for non-invasive CT and MRI scans free of metallic artifact for a more accurate patient follow-up assessment.
Press release: NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System